High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre.
Seijger, Charlotte; Hoefsloot, Wouter; Bergsma-de Guchteneire, Inge; Te Brake, Lindsey; van Ingen, Jakko; Kuipers, Saskia; van Crevel, Reinout; Aarnoutse, Rob; Boeree, Martin; Magis-Escurra, Cecile.
; 14(3): e0213718, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30870476
Six-month therapy for abdominal tuberculosis.
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.
Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis.
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.
Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses.